INTRODUCTION
Traditional medicines, as defined by WHO is the health
practices, approaches, knowledge, and beliefs incorporating
plant, animal, and mineral based medicines, spiritual
therapies, manual techniques and exercises, applied singularly
or in the combination to treat , diagnose, and prevent illnesses
or maintain well-being. There has been considerable evidence
of about 80 % of population residing in Asian and African
countries relying on traditional system of medicines.
According to the certain evidences available, the study
of herbs dates back to the 5000 years to the ancient
Sumerians, describing well established use of medicinal
plants. Many herbs and minerals used in Ayurveda were
described by ancient Indian herbalists such as Charaka and
Sushruta during the 1st millennium BC. [1]
The first pictorial evidence of herbal medicine, on the
walls of the Lascaux Caves in France, was radiocarbon dated
in between 13000 to 25000 B.C. Paracelsus 1493-1541
physician and botanist, originally known as Philippus
Theophrastus von Hohenheim, pioneered the use of
chemicals and minerals in medicine as well as plants, starting
the first ever use of plants in Medicine and toxicology. Cists
and burial sites dated to 1000 and 2000 B.C. have found
evidence of medicinal herbs being left with bodies. [2]
However, the first written record of herbal medicine use
showed up in 2800 B.C. in China (Titled Pen Tsao by Shen
Nung). It recorded around 252 plants descriptions and
describes their medicinal effects, including information about
on the places to grow these plants. Another written evidence
signals use of herbs in Mesopotamia (now Iraq) and in China
dates back to 3000 B.C. [3]
Times have changed now, as more and more people
seek to shift towards herbal medicines, the physicians and
researchers are again focusing back to traditional plants to
look for cure in support of challenging ailments and
Punica granatum L.
Historical significance of Pomegranates dates back to its
evidence available through the 800 year old, Kabbalistic
text, Sefera Rimon: The book of Pomegranates giving it an
position equivalent to Shekinah, the female aspect of
creation, and its creator. [5] Punica granatum commonly
known as Pomegranate is a fruit bearing deciduous shrub
or small tree growing between five and eight meters tall.
The name Pomegranate derives from the Medieval Latin
Pomum apple and granatum seeded. The genus name
Punica refers to the Phoenicians, who were active in
broadening its cultivation, partly for religious reasons.
185
REVIEW ARTICLE
Table 1: Classification of Punica granatum
Classification
Domain
Kingdom
Phylum
Class
Order
Family
Genus
Species
Type
Eukarya
Plantae
Magnaliophyta
Magnoliopsida
Myrtales
Punicaceae
Punica L.
Punica granatum
Table 2: Flower Differentiation [18]
Flower Characteristics
Length of pedicel to tip of sepals (mm)
Pistil Length (mm)
Stigma + style length
Ovary Height (mm)
Male
26.7 + 2.9
19.4 + 2.9
15.9 + 2.5
3.5 + 2.1
Wieght
Composition (%)
36.50
3.88
59.63
Total Phenolic
Content
3.17
1.69
0.32
Ellagic Acid
(mg/ 100 g)
100.0
50.2
3.1
Epicatechin
(g/100g)
1.28
0.81
ND
Kic ( g total
Phenolics/ ml
0.10+0.05
0.07+0.03
-
Catechin
(g/100g)
15.36
6.28
ND
Flower Morphology
Pomegranate had been grown as fruit crop since ancient
times. Flowering in Pomegranate is characterized as having
both hermaphroditic (bisexual) flowers and functionally
male flowers on the same plant, a condition referred to as
andromonoecy. The hermaphroditic flowers have wellformed female (stigma, style, ovary) and male (filament
186
REVIEW ARTICLE
Figure 5: Longitudnal
pomegranate flower
section
of
Figure 9: Underdeveloped
ovule in male flower
of both male and female flower parts occurs in all flowers, the
degree of development in petals flucatuates.
Temperature during the flowering period can have a
pronounced effect on reproductive processes. The effects
of temperature on pollen germination have been
significantly reduced at 5 and 15, whereas the highest
and similar germination were obtained at 25 and 35.
The timing of flower types can show seasonal and yearly
variations. [18-19]
187
REVIEW ARTICLE
Phytoconstituents
Punica granatum mainly constitutes polyphenols of which
are highly concentrated Ellagitannins, which are water
soluble phenolic compounds with high molecular weights.
[20] (Cuccioloni et al., 2009) carried out analysis of
percentage wise presence of monomeric polyphenols, and
188
REVIEW ARTICLE
189
REVIEW ARTICLE
190
REVIEW ARTICLE
191
REVIEW ARTICLE
192
REVIEW ARTICLE
Figure 24: Invitro anticancer studies using Punica granatum extract [67-74]
193
REVIEW ARTICLE
194
REVIEW ARTICLE
Figure 27: Pomegranate targeting osteoarthiritis inducer (novel target therapy lead) [79]
Antioxidant Activity
There is no doubt about the mentioned activity, as texted
earlier the presence of different phytoconstituents,
especially phenolic compounds, polyphenols, flavanoids,
and hydrolysable tannins, depict 92 % of total antioxidant
activity present in the plant Pomegranate.
Another confirmation comes from the experimental
report published by (Moneim A.E.A, 2012), who studied the
antioxidant properties in Pomegranate on rat brains.
Findings gave positive feedback of polyphenols except
catechol tannins, since it was absent in the methanolic
extract, on the reduction in Reactive oxygen species (ROS),
reduction in superoxide dismutase, hydrogen peroxide,
and hydroxyl (*OH) generated capable of damaging cell
lines, and DNA.
The result proved Pomegranate as a powerful
antioxidant lead for medicine development. [77]
Probiotic Enhancer
(Bialonska et al., 2010) reported the positive effects of
Pomegranate on the gut microbial environment. The study
found Pomegranate effective in enhancing the growth of
probiotics for e.g Bifidobacterium spp., Lactobacillus
Enterococcus species. Thus, making it suitable lead to
strengthening immune and defense mechanisms of the
body. [78]
Osteoarthiritis Treatment
(Rasheed et al., 2010) studied the proliferation factor
responsible for pathogenesis of Osteoarthiritis and found,
p38-MAPK (Mitogen activated protein kinases) as a major
signal-transducing
pathway
in
pathogenesis
of
Osteoarthiritis, activated further via interleukin-1 leading
to plethora of generation of mediators for Osteoarthiritis.
The researcher experimented the effect of Pomegranate
extract on the chondrocyte cells isolated from
Osteoarthritis affected cartilage via enzymatic digestion.
The pathogenesis of degradation was observed after IL-1
stimulation. Gene expressions of p38-MAPK were observed
and measured by RT-PCR. The results showed a promising
treatment lead for Osteoarthiritis, as it was observed that
Fighting Depression
(Okomoto et al., 2004) found pomengrate effective in bone
mineral density maintenance even after the presence of
strong stimulator ovariectomy leading to sudden
depression in bone mineral density. The researcher
selected Pomegranate for studying menopausal
syndrome, on the basis of estrogenic effect proven in the
plant earlier. The estrogenic effects were due to the
presence of Estradiol, estrone and estriol. Ovariectomy
induces sudden increase in body weight; this was
inhibited by the constant administration of Pomegranate
juice. [76]
195
REVIEW ARTICLE
Pomegranate extract suppressed IL-1 induced activation
of MKK3(Mitogen activated prtotein kinase kinsase), p38MAPK isoform and DNA binding activity of the
transcription factor RUNX-2(Runt-related transcriptioin
factor 2. [79]
Antimutagenic Activity
(Zahin et al., 2010) experimented the antioxidant and
antimutagenic potential in the peel extracts of the plant
Punica granatum. The antioxidant activity was tested via
DPPH free radical scavenging, phosphomolybednum, Ferric
reducing power and Cupric reducing ability assays. The
methanolic extract showed the highest antioxidant activity
compared to other solvent fractions such as ethanol,
acetone, and ethyl acetate fractions. Antimutagenic activity
was explored via Ames Salmonella/ microsome assay
against sodium azide (NaN3), methyl methane sulphonate
(MMS),
2-aminofluorene (2-AF) and benzo(a)pyrene
induced mutagenicity in Salmonella typhimurium tester
strains. [84]
Memory Enhancing and Learning Potential
(Adiga et al., 2010) has reported positive memory
enhancing effect in the peel extracts of Punica granatum.
The tests were confirmed with the help of T-maze test or
passive avoidance test at dose of 50mg.kg and 100 mg.kg
dose of peel extracts of plant Punica granatum. [85]
Cardioprotective Role
(Mohan et al., 2012) studied the dose dependent inhibition
of Isoprterenol (85 mg/kg, administered subcutaneously
twice to rats) induced increase in heart rate, elevation in
electrocardiogram, vascular reactivity to catecholamines,
increase in levels of cardiac-marker enzymes-lactate
dehydrogenase, creatine kinase, reduction in superoxide
dismutase. Doses of (100mg/kg and 300mg/kg, p.o) of
Pomegranate extract showed significant proof of potential
cardiotonic lead. [81]
Antimalaria
(DellAgli et al., 2010) carried out an in-vitro analysis of the
Pomegranate extract in the treatment of malaria caused by
Plasmodium falciparum involved in inflammatory cytokinedriven diseaee associated with upregulation and activity of
metalloproteinase-9 and to the increase of TNF production.
The methanolic extract enriched in tannins was prepared
inhibited the secretion of MMP-9 induced by haemozoin or
TNF. The effect occurred at transcriptional level since MMP9 mRNA levels are lower in the presence of tested
compounds. Thus the Pomegranate depicts its anti-malarial
effect via anti-parasitic activity and inhibition of proinflammatory response in the onset of cerebral malaria. The
Methanolic extract of Pomegranate showed inhibition of
secretion of MMP-9 (Matrixmetallopeptidase 9), by 61 %. [82]
Antifungal Activity
(Duraipandiyan et al., 2011) studied forty five medicinal
plants collected from different parts of Tamil Nadu. Hexane,
ethyl acetate, and methanol extract of the forty five
medicinal plant extracts were investigated for potential
antifingal activity. Punica granatum was one of the plant
which showed positive test results with having broad
spectrum antifungal property. [87]
Cytochrome P Inhibitory Effect
(Usia et al., 2006) analyzed inhibition of in-vitro
metabolism by cytochrome P450 3A4 and CYP 2D6.
Cytochrome are enzyme involved in metabolism of many
drugs, and leading to early offset of drug activity in body of
medicines given for treatment. CYP3A4, the major hepatic
and intestinal CYP in humans, metabolizes more than 50 %
of clinically used drugs such as cyclosporine A,
dihydropyridine, ethinylestradiol, midazolam, terfenadine,
and triazolam. CYP2D6 catalyzes drugs like amitriptyline,
imipramine,
haloperidol,
propranolol
and
Antidiabetic Potential
(Patil et al., 2011) reported in his survey of antidiabetic
activity plants, a special mention of Punica granatum,
where it clearly highlights the use of methanolic extract of
the plant at dose range of 500 mg/ kg in normalizing the
plasma glucose level in alloxan induced diabetic
196
REVIEW ARTICLE
12. Levin GM. Pomegranate (Punica granatum) plant genetic
resources in Turkmenistan. Plant Genetic Resources
Newsletter, 97:3137, 1994.
13. Punica granatum: The pomegranate Tree [Online].2007 [cited
2012 July 11]; Accessed from URL: http://bioweb.uwlax.edu
/bio203/2011/kruse_sara/classification.html.
14. Holland D, Hatib K, and Yaakov-Bar I. Pomegranate: Botany,
horticulture, breeding. Horticulture Review. Horticulture
Science, 35: 127191, 2009.
15. Shulman Y, Fainberestein L, and Lavee S. Pomegranate fruit
development and maturation. Horticulture Science, 59:265
274, 1984.
16. Chaudhari MS and Desai TU. Effects of plant growth regulators
on flower sex in pomegranate (Punica granatum L.).
Agriculture Science 63:3435, 1993.
17. DeMason AD and Stolte WK. Floral development in Phoenix
dactylifera. Botanical, 60:14371446, 1982.
18. Wetzstein YH, Ravid N, Wilkins E, Martinelli PA. A
morphological and histological characterization of bisexual
and male flower types in Pomengranate. American social
horticulture science, 136(2):83-92, 2011.
19. Cuccioloni M, Mozzicafreddo M, Sparapani L, Spina M, Eleuteri
MA, Fioretti E, et al. Pomengranate fruit components modulate
human thrombin. Fitoterapia, 80:301-305, 2009.
20. Lee IS, Kim SB, Kim SK, Lee S, Shin SK, Lim SJ. Immunesuppresive activity of punicalagin via inhibition of NFAT
activation.Biochemical
and
Biophysical
Research
communications, 371: 799-803, 2008.
21. Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, Kader
AA. Agriculture Food Chemistry, 48:4581-9, 2000.
22. Clifford NM, Scalbert A. Food agriculture, 118, 2000.
23. Chauhan D, Chauhan SJ, Pharmaceutical Biology, 39:155, 2001.
24. Toumy AS, Rauwald WH.Phytochemistry, 61:971, 2002.
25. Poyrazoglu E, Gokmen V, Aruk N. Food compositaea analysis,
15:567, 2002.
26. Heftmann E, Ko TS, Bennett DR.Phytochemistry, 5:1337, 1966.
27. Alighourchi H, Barzegar M, Abbasi S. Anthocyanins
characterization of 15 Iranian pomegranate (Punica granatum
L.) varieties and their variation during cold storage and
pasteurization. European Food Research and Technology,
228:881887, 2008.
28. Jain V, Murugananthan G, Deepak M, Vishwanatha LG,
Manohar D. Isolation and standardization of various
phytochemical constituents from methanolic extracts of fruit
rinds of Punica granatum. Natural medicines, 9(6):0414-0420,
2011.
29. Balwani S, Nandi D, Jaisankar Ghosh B. 2-Methyl-pyran-4-one3-O-b-D-glucopyranoside isolated from leaves of Punica
granatum inhibits the TNFa-induced cell adhesion molecules
expression by blocking nuclear transcription factor-kB (NFkB). Biochimie, 93:921-930, 2011.
30. Zhang L, Fu Q, Zhang Y. Composition of anthocyanins in
pomengranate flowers and their antioxidant activities. Food
chemistry, 127:1444-1449, 2011.
31. Cui SM, Sasada Y, Sato H, Nii N. Cell structure and sugar and
acid contents in the arils of developing pomegranate fruit.
Journal of the Japanese Society for Horticultural Science,
73:241243, 2004.
32. Gabbasova LB, Abdurazakova SK. Chemical composition of
pomegranate juice] Izvestiya Vysshikh Uchebnykh Zavedenii.
Pischevaya Tekhnologiya: Nauchno-Tekhnicheskii Zhurnal,
4:3031, 1969.
33. Poyrazoglu E, Goekmen V, Artik N. Organic acids and phenolic
compounds in pomegranates (Punica granatum L.) grown in
Turkey. Journal of Food Composition and Analysis, 15:567
575, 2002.
197
REVIEW ARTICLE
52. Schubert SY, Lansky EP, Neeman I. Antioxidant and eicosanoid
enzyme inhibition properties of pomegranate seed oil and
fermented juice flavonoids. Ethnopharmacology, 66:1117,
1999.
53. Hopkins CY, Chisholm MJ. A survey of the conjugated fatty
acids of seed oils. Journal of the American Oil Chemists Society
45:176182, 1968.
54. Hornung E, Pernstich C, Feussner I. Formation of conjugated
_11_13-double bonds by _12-linoleic acid (1,4)-acyl-lipiddesaturase in pomegranate seeds. European Journal of
Biochemistry, 269:48524859, 2002.
55. Abd ElWahab SM, El Fiki, NM, Mostafa SF, Hassan AEB.
Characterization of certain steroid hormones in Punica
granatum L. seeds. Bulletin of the Faculty of Pharmacy (Cairo
University), 36:1115, 1998.
56. Dean PDG, Exley D, Goodwin TW. Steroid oestrogens in plants:
re-estimation of oestrone in pomegranate seeds.
Phytochemistry, 10:22152216, 1971.
57. Kim MM, Kim S. Composition for improving oral hygiene
containing Punica granatum L. extract. Korean Patent: KR
2002066042. 2000.
58. Ahmed R, Ifzal SM, Saifuddin A, Nazeer M. Studies on Punica
granatum. I. Isolation and identification of some constituents
from the seeds of Punica granatum. Pakistan Pharmaceutical
Sciences, 8:6971, 1995.
59. Huang TH, HYang Q, Harada M, Li GQ, Yamahara J, Roufogalis
BD, Li Y. Pomegranate flower extract diminishes cardiac
fibrosis in Zucker diabetic fatty rats: modulation of cardiac
endothelin-1 and nuclear factor-kappaB pathways. Journal of
Cardiovascular Pharmacology, 46:856862, 2005c.
60. Huang TH, HPeng G, Kota BP, Li GQ, Yamahara J, Roufogalis BD,
Li Y. Pomegranate flower improves cardiac lipid metabolism in
a diabetic rat model: role of lowering circulating lipids. British
Journal of Pharmacology, 145:767774, 2005a.
61. Tsuyuki H, Ito S, Nakatsukasa Y. Lipids in pomegranate seeds.
Nihon Daigaku No-Juigakubu Gakujutsu Kenkyu Hokoku,
38:141148, 1981.
62. Moneam NM, el Sharaky AS, Badreldin MM, Oestrogen content
of pomegranate seeds. Chromatography, 438:438442, 1988.
63. Tiwari P, Kumar B, Kaur M, Kaur G, Kaur H. Phytochemical
screening
and
extraction:
A
Review.International
Pharmaceutica Sciencia, 1(1):98-106, 2011.
64. Prashant D, Asha KM, Amit A. Antibacterial activity of Punica
granatum.Short Review.Fitoterapia, 72:171-173, 2001.
65. Rathinamoorthy R, Udayakumar S, Thilagavathi G.
Antibacterial efficacy analysis of Punica granatum L. leaf, rind
and Terminalia chebule fruit extract treated cotton fabric
against five most common human pathogenic bacteria.
Pharmacy and Life sciences, 2(10):1147-1153, 2011.
66. Syed DN, Malik A, Hadi N, Sarfaraz S, Afaq F, Mukhtar H.
Photochemopreventive effect of pomegranate fruit extract on
UVA-mediated activation of cellular pathways in normal
human
epidermal
keratinocytes.
Photochemistry
Photobiology, 82:398405, 2007.
67. Pantuck AJ, Leppert JT, Zomorodian N, AronsonW, Hong J, Barnard
RJ, et al. Phase II study of pomegranate juice for men with rising
prostate-specific antigen following surgery or radiation for prostate
cancer. Clinical Cancer Research, 12:401826, 2006.
68. Khan N, Afaq F, Kweon M-H, Kim KM, Mukhtar H. Oral
consumption of pomegranate fruit extract inhibits growth and
progression of primary lung tumors in mice. Cancer Research,
67:347582, 2007.
69. Kim ND, Mehta R, Yu W, Neeman I, Livney T, Amichay A, et al.
Chemopreventive and adjuvant therapeutic potential of
pomegranate (Punica granatum) for human breast cancer.
Breast Cancer Research Treatment, 71:20317, 2002.
198
REVIEW ARTICLE
80. Cuccioloni M, Mozzicafreddo M, Sparagani L, Spina M, Eleuteri
MA, Fioretti E, Angeletti M. Pomegranate fruit components
modulate human thrombin.Fitoterapia, 80:301-305, 2009.
81. Mohan M, Patankar P, Ghadi P, Kasture S. Cardioprotective
potential of Punica granatum in isoproterenol-induced
myocardial infarction in wistar rats.Pharmacology and
Pharmacotherapeutics, 1(1):32-37, 2010.
82. DellAgli M, Galli VG, Bulgari M, Basilico N, Romeo S,
Bhattacharya D. Ellagitanins of the fruit rind of pomengranate
(Punica granatum) antagonize in vitro the host inflammatory
response mechanism involved in the onset of malaria.Malaria
Journal, 9:208, 2010.
83. Patil R, Patil R, Ahirwar B, Ahirwar D. Current status of Indian
medicinal
plants
with
antidiabetic
potential:
A
Review.Tropical biomedicine, S291-S298, 2011.
84. Zahim M, Aqil F, Ahmad I. Broad spectrum antimutagenic
activity of antioxidant active fraction of Punica granatum L.
peel extracts.Mutation research/Genetic toxicology and
Environmental Mutagenesis, 703:99-107, 2010.
85. Adiga S, Trivedi P, Ravichandra V, Deb D, Mehta F. Effect of
Punica granatum peel extract on learning and memory in
rats.Tropical Medicine,687-690, 2010.
86. Kamaraj C, Rahuman AA. Larvicidal and adulticidal potential
of medicinal plant extracts from south India against
vectors.Tropical Medicine, 948-953, 2010.
87. Duraipandiyan V, Ignacimuthu S. Antifungal activity of
traditional medicinal plants from Tamil Nadu, India.Tropical
Biomedicine, S204-S215, 2011.
88. Usia T, Iwata H, Hiratsuka A,Watabe T, Kadota S, Tezuka Y.
CYP3A4 and CYP2D6 inhibitory activites of Indonesian
medicinal plants.Phytomedicine,13:67-73, 2006.
70. Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber
D. Pomegranate juice, total pomegranate ellagitannins, and
punicalagin suppress inflammatory cell signaling in colon
cancer cells. Agriculture Food Chemistry, 54:9805, 2006.
71. Kawaii S, Lansky EP. Differentiation-promoting activity of
pomegranate (Punica granatum) fruit extracts in HL-60
human promyelocytic leukemia cells. Medicinal Food, 7:138,
2004.
72. Mukhtar H, Ahmad N. Cancer chemoprevention: future holds
in multiple agents. Toxicol Applied Pharmacology, 158:207
10, 1998.
73. Catalan BE, Arroyo FS, Saura D, Guillen E, Gutieerre FA,
Carretero SA, et al. Cistaceae aqueous extracts containing
ellagitannins show antioxidant and antimicrobial capacity, and
cytotoxic activity.Food and Chemical toxicology, 48:22732282, 2010.
74. Lansky EP, Newman RA. Punica granatum (pomegranate) and
its potential for prevention and treatment of inflammation and
cancer, Ethnopharmacology, 109:177206, 2007.
75. Rosillo AM, Hidalgo SM, Cardeno A, Lastra ld CA. Protective
effect of ellagic acid, a natural polyphenolic compound, in a
murine model of Crohns disease.Biochemical Pharmacology,
82:737-745, 2011.
76. Okamato MJ, Hamamoto OY, Yamato H, Yoshimura H.
Pomengranate extract improves a depressive state and bone
properties in menopausal syndrome model ovariectomized
mice.Ethnopharmacology,92:93-101, 2004.
77. Monein AEA. Antioxidant activities of Punica granatum
(pomengranate) peel extract on brain of rats.Medicinal plants
Research, 6(2):195-199, 2012.
78. Bailonska D, Ramnani P, Kasimsetty GS, Muntha RK, Gibson
RG, Ferreira D. The influence of pomengranate by product
and punicalagins on selected groups of human intestinal
microbiota. Food microbiology, 140:175-182, 2010.
79. Rasheed Z, Akhtar N, Haqqi MT. Pomengranate extract inhibits
the interleukin-1-induced activation of MKK-3, p38-MAPK,
and transcription factor RUNX-2 in human osteoarthiritis
chondrocytes.Arthiritis Research & Therapy, 12:R195, 2010.
199